Drug Shortage Report for ACETYLCYSTEINE SOLUTION USP

Last updated on 2021-04-22 History
Report ID 85112
Drug Identification Number 02459906
Brand name ACETYLCYSTEINE SOLUTION USP
Common or Proper name Acetylcysteine
Company Name HIKMA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) ACETYLCYSTEINE
Strength(s) 200MG
Dosage form(s) SOLUTION
Route of administration INHALATION INTRAVENOUS ORAL
Packaging size 10ml
ATC code R05CB
ATC description EXPECTORANTS,EXCL COMBINATIONS WITH COUGH SUPPR.
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2019-05-28
Actual start date
Estimated end date 2021-04-21
Actual end date 2021-04-21
Shortage status Resolved
Updated date 2021-04-22
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 5995 AVEBURY ROAD, SUITE 804
MISSISSAUGA, ONTARIO
CANADA L5R 3P9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2019-05-28 English Compare
v2 2019-05-28 French Compare
v3 2019-05-29 English Compare
v4 2019-12-10 English Compare
v5 2019-12-10 French Compare
v6 2020-11-09 English Compare
v7 2020-11-09 French Compare
v8 2021-01-29 English Compare
v9 2021-01-29 French Compare
v10 2021-02-26 English Compare
v11 2021-02-26 French Compare
v12 2021-03-12 English Compare
v13 2021-03-12 English Compare
v14 2021-03-12 French Compare
v15 2021-03-26 English Compare
v16 2021-03-26 French Compare
v17 2021-04-21 English Compare
v18 2021-04-21 French Compare
v19 2021-04-22 English Compare

Showing 1 to 19 of 19